Equities

On 14 June, the Federal Reserve raised short-term rates by another 25bps from 1% to 1.25%, despite fairly weak inflation figures.

Declining smoking statistics

Views from WHEB Asset Management

BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.

Classes A and D remain unavailable

Bringing over two funds

Set to list in next two weeks

South Korea looks attractive

14 funds would have be affected

Favouring non-sterling denominated bonds